Peter F. Schmid
AuthID: R-000-QRP
1
TÃTULO: XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
AUTORES: Schmid, Peter; Cortes, Javier; Joaquim, Ana; Janez, Noelia Martinez; Morales, Serafin; Diaz Redondo, Tamara; Blau, Sibel; Neven, Patrick; Lemieux, Julie; Garcia Saenz, Jose Angel; Hart, Lowell; Biyukov, Tsvetan; Baktash, Navid; Massey, Dan; Burris, Howard A., III; Rugo, Hope S.;
PUBLICAÇÃO: 2023, FONTE: BREAST CANCER RESEARCH, VOLUME: 25, NÚMERO: 1
AUTORES: Schmid, Peter; Cortes, Javier; Joaquim, Ana; Janez, Noelia Martinez; Morales, Serafin; Diaz Redondo, Tamara; Blau, Sibel; Neven, Patrick; Lemieux, Julie; Garcia Saenz, Jose Angel; Hart, Lowell; Biyukov, Tsvetan; Baktash, Navid; Massey, Dan; Burris, Howard A., III; Rugo, Hope S.;
PUBLICAÇÃO: 2023, FONTE: BREAST CANCER RESEARCH, VOLUME: 25, NÚMERO: 1
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 Study Full Text
AUTORES: Kuemmel, Sherko; Schmid, Peter; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Boileau, Jean Francois; Cortes, Javier; McArthur, Heather; Dent, Rebecca; O'Shaughnessy, Joyce; Pusztai, Lajos; Foukakis, Theodoros; Park, Yeon Hee; Hui, Rina; Cardoso, Fatima; Denkert, Carsten; Zhu, Yalin; Pan, Wilbur; Karantza, Vassiliki; Fasching, Peter A.;
PUBLICAÇÃO: 2023, FONTE: 24th Annual Meeting of The American Society of Breast Surgeons (ASBrS) in ANNALS OF SURGICAL ONCOLOGY, VOLUME: 30, NÚMERO: SUPPL 2
AUTORES: Kuemmel, Sherko; Schmid, Peter; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Boileau, Jean Francois; Cortes, Javier; McArthur, Heather; Dent, Rebecca; O'Shaughnessy, Joyce; Pusztai, Lajos; Foukakis, Theodoros; Park, Yeon Hee; Hui, Rina; Cardoso, Fatima; Denkert, Carsten; Zhu, Yalin; Pan, Wilbur; Karantza, Vassiliki; Fasching, Peter A.;
PUBLICAÇÃO: 2023, FONTE: 24th Annual Meeting of The American Society of Breast Surgeons (ASBrS) in ANNALS OF SURGICAL ONCOLOGY, VOLUME: 30, NÚMERO: SUPPL 2
INDEXADO EM: WOS
WOS3
TÃTULO: Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
AUTORES: Schmid, P; Cortes, J; Dent, R; Pusztai, L; McArthur, H; Kummel, S; Bergh, J; Denkert, C; Park, YH; Hui, R; Harbeck, N; Takahashi, M; Untch, M; Fasching, PA; Cardoso, F; Andersen, J; Patt, D; Danso, M; Ferreira, M; Mouret Reynier, MA; ...Mais
PUBLICAÇÃO: 2022, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 386, NÚMERO: 6
AUTORES: Schmid, P; Cortes, J; Dent, R; Pusztai, L; McArthur, H; Kummel, S; Bergh, J; Denkert, C; Park, YH; Hui, R; Harbeck, N; Takahashi, M; Untch, M; Fasching, PA; Cardoso, F; Andersen, J; Patt, D; Danso, M; Ferreira, M; Mouret Reynier, MA; ...Mais
PUBLICAÇÃO: 2022, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 386, NÚMERO: 6
INDEXADO EM: WOS
WOS4
TÃTULO: Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+breast cancer: a plain language summary of the PHERGain study
AUTORES: Perez Garcia, Jose Manuel; Gebhart, Geraldine; Borrego, Manuel Ruiz; Schmid, Peter; Marme, Frederik; Prat, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofia; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio;
PUBLICAÇÃO: 2022, FONTE: FUTURE ONCOLOGY
AUTORES: Perez Garcia, Jose Manuel; Gebhart, Geraldine; Borrego, Manuel Ruiz; Schmid, Peter; Marme, Frederik; Prat, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofia; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio;
PUBLICAÇÃO: 2022, FONTE: FUTURE ONCOLOGY
INDEXADO EM: WOS
WOS5
TÃTULO: Neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy, followed by adjuvant pembrolizumab versus placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses from KEYNOTE-522 Full Text
AUTORES: Schmid, Peter; Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Andersen, Jay; Patt, Debra; Danso, Michael; Ferreira, Marta; Mouret Reynier, Marie Ange; ...Mais
PUBLICAÇÃO: 2022, FONTE: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 18
AUTORES: Schmid, Peter; Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Andersen, Jay; Patt, Debra; Danso, Michael; Ferreira, Marta; Mouret Reynier, Marie Ange; ...Mais
PUBLICAÇÃO: 2022, FONTE: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 18
INDEXADO EM: WOS
WOS6
TÃTULO: Phase 3, randomized, double-blind, placebo-controlled study of pembrolizumab plus chemotherapy in patients with HR+/HER2-locally recurrent inoperable or metastatic breast cancer (mBC): KEYNOTE-B49 Full Text
AUTORES: Schmid, Peter; Sohn, Joo Hyuk; Jerez Gilarranz, Yolanda; Gonzalez Cortijo, Lucia; Sonnenblick, Amir; Sabanathan, Dhanusha; Korbenfeld, Ernesto; Egle, Daniel; Poirier, Brigitte; Zagouri, Flora; Matikas, Alexios; Aksoy, Sercan; Demirci, Umut; Ramos Elias, Pier; Im, Seock Ah; Cardoso, Fatima; Jia, Liyi; Hirshfield, Kim; Tryfonidis, Konstantinos; Rugo, Hope S.;
PUBLICAÇÃO: 2022, FONTE: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 18
AUTORES: Schmid, Peter; Sohn, Joo Hyuk; Jerez Gilarranz, Yolanda; Gonzalez Cortijo, Lucia; Sonnenblick, Amir; Sabanathan, Dhanusha; Korbenfeld, Ernesto; Egle, Daniel; Poirier, Brigitte; Zagouri, Flora; Matikas, Alexios; Aksoy, Sercan; Demirci, Umut; Ramos Elias, Pier; Im, Seock Ah; Cardoso, Fatima; Jia, Liyi; Hirshfield, Kim; Tryfonidis, Konstantinos; Rugo, Hope S.;
PUBLICAÇÃO: 2022, FONTE: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 18
INDEXADO EM: WOS
WOS7
TÃTULO: Enhancing global access to cancer medicines Full Text
AUTORES: Javier Cortes; Jose Manuel Perez Garcia; Antonio Llombart Cussac; Giuseppe Curigliano; Nagi S El Saghir; Fatima Cardoso; Carlos H Barrios; Shama Wagle; Javier Roman; Nadia Harbeck; Alexandru Eniu; Peter A Kaufman; Josep Tabernero; Laura Garcia Estevez; Peter Schmid; Joaquin Arribas;
PUBLICAÇÃO: 2020, FONTE: CA-A CANCER JOURNAL FOR CLINICIANS, VOLUME: 70, NÚMERO: 2
AUTORES: Javier Cortes; Jose Manuel Perez Garcia; Antonio Llombart Cussac; Giuseppe Curigliano; Nagi S El Saghir; Fatima Cardoso; Carlos H Barrios; Shama Wagle; Javier Roman; Nadia Harbeck; Alexandru Eniu; Peter A Kaufman; Josep Tabernero; Laura Garcia Estevez; Peter Schmid; Joaquin Arribas;
PUBLICAÇÃO: 2020, FONTE: CA-A CANCER JOURNAL FOR CLINICIANS, VOLUME: 70, NÚMERO: 2
INDEXADO EM: Scopus WOS
Scopus WOS8
TÃTULO: Pembrolizumab for Early Triple-Negative Breast Cancer
AUTORES: Peter Schmid; Javier Cortes; Lajos Pusztai; Heather McArthur; Sherko Kuemmel; Jonas Bergh; Carsten Denkert; Yeon Hee Park; Rina Hui; Nadia Harbeck; Masato Takahashi; Theodoros Foukakis; Peter A Fasching; Fatima Cardoso; Michael Untch; Liyi Jia; Vassiliki Karantza; Jing Zhao; Gursel Aktan; Rebecca Dent; ...Mais
PUBLICAÇÃO: 2020, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 382, NÚMERO: 9
AUTORES: Peter Schmid; Javier Cortes; Lajos Pusztai; Heather McArthur; Sherko Kuemmel; Jonas Bergh; Carsten Denkert; Yeon Hee Park; Rina Hui; Nadia Harbeck; Masato Takahashi; Theodoros Foukakis; Peter A Fasching; Fatima Cardoso; Michael Untch; Liyi Jia; Vassiliki Karantza; Jing Zhao; Gursel Aktan; Rebecca Dent; ...Mais
PUBLICAÇÃO: 2020, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 382, NÚMERO: 9
INDEXADO EM: Scopus WOS
Scopus WOS9
TÃTULO: Chemotherapy (CT) de-escalation using an FDG-PET/CT (F-PET) and pathological response-adapted strategy in HER2[+] early breast cancer (EBC): PHERGain Trial.
AUTORES: Javier Cortes; Geraldine Gebhart; Manuel Ruiz Borrego; Agostina Stradella; Begona Bermejo; Santiago Escriva; Lourdes Calvo Martinez; Nuria Ribelles; Noelia Martinez; Cinta Albacar; Aleix Prat; Florence Dalenc; Kerrou Khaldoun; Peter Schmid; Marco Colleoni; Frederik Marme; Noemia Afonso; Miguel Sampayo Cordero; Jose Manuel Perez Garcia; Antonio Llombart Cussac;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 15
AUTORES: Javier Cortes; Geraldine Gebhart; Manuel Ruiz Borrego; Agostina Stradella; Begona Bermejo; Santiago Escriva; Lourdes Calvo Martinez; Nuria Ribelles; Noelia Martinez; Cinta Albacar; Aleix Prat; Florence Dalenc; Kerrou Khaldoun; Peter Schmid; Marco Colleoni; Frederik Marme; Noemia Afonso; Miguel Sampayo Cordero; Jose Manuel Perez Garcia; Antonio Llombart Cussac;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 15
INDEXADO EM: WOS
WOS10
TÃTULO: Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer The MANTA Phase 2 Randomized Clinical Trial
AUTORES: Peter Schmid; Matthias Zaiss; Catherine Harper Wynne; Marta Ferreira; Sidharth Dubey; Stephen Chan; Andreas Makris; Gia Nemsadze; Adrian M Brunt; Sherko Kuemmel; Isabel Ruiz; Antonia Perello; Anne Kendall; Janet Brown; Hartmut Kristeleit; John Conibear; Cristina Saura; Julien Grenier; Karoly Mahr; Michael Schenker; ...Mais
PUBLICAÇÃO: 2019, FONTE: JAMA ONCOLOGY, VOLUME: 5, NÚMERO: 11
AUTORES: Peter Schmid; Matthias Zaiss; Catherine Harper Wynne; Marta Ferreira; Sidharth Dubey; Stephen Chan; Andreas Makris; Gia Nemsadze; Adrian M Brunt; Sherko Kuemmel; Isabel Ruiz; Antonia Perello; Anne Kendall; Janet Brown; Hartmut Kristeleit; John Conibear; Cristina Saura; Julien Grenier; Karoly Mahr; Michael Schenker; ...Mais
PUBLICAÇÃO: 2019, FONTE: JAMA ONCOLOGY, VOLUME: 5, NÚMERO: 11
INDEXADO EM: Scopus WOS
Scopus WOS